Clinical Trial Update: Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated Nerinetide in acute ischemic stroke patients undergoing endovascular thrombectomy without thrombolysis. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Nerinetide (nerinetide)

Snippet

Sponsor: NoNO Inc. | Conditions: Stroke, Acute | Phase 3 | Status: COMPLETED | Results posted: 2025-06-22